Protein glycosylation is fundamentally important to most biological processes and it is often important to regulate it in biopharmaceutical development. Thus, substantial efforts have been taken to engineer glycosylation of a variety of biologics. However, the diversity and complexity of glycosylation have made it difﬁcult to control glycosylation and unravel how engineering efforts impact the host cells.
|Conference||2018 Annual Meeting of the Society for Glycobiology |
|Location||Hilton New Orleans Riverside|
|Period||05/11/2018 → 08/11/2018|